Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Bio-Thera’s Bevacizumab US Action Date Passes Without Approval
Chinese Developer And Partner Sandoz Remain Quiet On Fate Of Avastin Biosimilar
Dec 01 2021
•
By
David Wallace
The 27 November action date has come and gone • Source: Alamy
More from Biosimilars
More from Products